1. Home
  2. NVO vs ORCL Comparison

NVO vs ORCL Comparison

Compare NVO & ORCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVO
  • ORCL
  • Stock Information
  • Founded
  • NVO 1923
  • ORCL 1977
  • Country
  • NVO Denmark
  • ORCL United States
  • Employees
  • NVO N/A
  • ORCL N/A
  • Industry
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • ORCL Computer Software: Prepackaged Software
  • Sector
  • NVO Health Care
  • ORCL Technology
  • Exchange
  • NVO Nasdaq
  • ORCL Nasdaq
  • Market Cap
  • NVO 530.0B
  • ORCL 465.2B
  • IPO Year
  • NVO N/A
  • ORCL 1986
  • Fundamental
  • Price
  • NVO $88.08
  • ORCL $167.83
  • Analyst Decision
  • NVO Strong Buy
  • ORCL Buy
  • Analyst Count
  • NVO 4
  • ORCL 28
  • Target Price
  • NVO $141.67
  • ORCL $186.24
  • AVG Volume (30 Days)
  • NVO 9.5M
  • ORCL 11.0M
  • Earning Date
  • NVO 02-05-2025
  • ORCL 03-10-2025
  • Dividend Yield
  • NVO 1.48%
  • ORCL 0.95%
  • EPS Growth
  • NVO 21.54
  • ORCL 13.17
  • EPS
  • NVO 3.14
  • ORCL 4.09
  • Revenue
  • NVO $40,314,376,667.00
  • ORCL $54,933,000,000.00
  • Revenue This Year
  • NVO $21.96
  • ORCL $11.14
  • Revenue Next Year
  • NVO $17.13
  • ORCL $12.63
  • P/E Ratio
  • NVO $26.45
  • ORCL $41.02
  • Revenue Growth
  • NVO 25.03
  • ORCL 6.40
  • 52 Week Low
  • NVO $77.82
  • ORCL $109.79
  • 52 Week High
  • NVO $148.15
  • ORCL $198.31
  • Technical
  • Relative Strength Index (RSI)
  • NVO 56.29
  • ORCL 45.38
  • Support Level
  • NVO $77.82
  • ORCL $170.71
  • Resistance Level
  • NVO $88.95
  • ORCL $182.24
  • Average True Range (ATR)
  • NVO 1.88
  • ORCL 4.72
  • MACD
  • NVO 0.71
  • ORCL -0.00
  • Stochastic Oscillator
  • NVO 89.92
  • ORCL 24.29

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About ORCL Oracle Corporation

Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.

Share on Social Networks: